Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The "hidden" epidemic: a snapshot of Moroccan intravenous drug users.

Trimbitas RD, Serghini FZ, Lazaar F, Baha W, Foullous A, Essalhi M, El Malki A, Meziane Bellefquih A, Bennani A.

Virol J. 2014 Mar 6;11:43. doi: 10.1186/1743-422X-11-43.

2.

Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users.

Trimbitas RD, Fayssel N, Serghini FZ, Wakrim L, Khyatti M, Essalhi M, Bellefquih AM, Benani A.

J Med Virol. 2016 Aug;88(8):1376-83. doi: 10.1002/jmv.24470. Epub 2016 Feb 12.

PMID:
26754854
3.

HCV genotypes in Morocco.

Benani A, El-Turk J, Benjelloun S, Sekkat S, Nadifi S, Hda N, Benslimane A.

J Med Virol. 1997 Aug;52(4):396-8.

PMID:
9260687
4.

Active hepatitis C infection and HCV genotypes prevalent among the IDUs of Khyber Pakhtunkhwa.

ur Rehman L, Ullah I, Ali I, Khan IA, Iqbal A, Khan S, Khan SH, Zaman KU, ullah Khan N, Swati ZA, Jahangiri AT.

Virol J. 2011 Jun 28;8:327. doi: 10.1186/1743-422X-8-327.

5.

Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection.

Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R.

Addiction. 2009 Nov;104(11):1881-90. doi: 10.1111/j.1360-0443.2009.02687.x. Epub 2009 Aug 27.

6.

Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China.

Du H, Qi Y, Hao F, Huang Y, Mao L, Ji S, Huang M, Qin C, Yan R, Zhu X, Zhang C.

J Clin Virol. 2012 Jul;54(3):207-12. doi: 10.1016/j.jcv.2012.04.017. Epub 2012 May 16.

PMID:
22595306
7.

Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.

Calado RA, Rocha MR, Parreira R, Piedade J, Venenno T, Esteves A.

J Med Virol. 2011 Apr;83(4):608-15. doi: 10.1002/jmv.21955.

PMID:
21328374
8.

[Evolutionary characteristics and positive selection site of hepatitis C virus isolated in intravenous drug users in Pudong new district, Shanghai].

Wang Y, Wu HY, Zhao XC, Zhu WP, Wan Q, Lu YH, Jiang QW.

Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Mar 10;38(3):378-383. doi: 10.3760/cma.j.issn.0254-6450.2017.03.021. Chinese.

PMID:
28329944
9.

Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.

Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS.

PLoS One. 2008;3(10):e3608. doi: 10.1371/journal.pone.0003608. Epub 2008 Oct 31.

10.

Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.

Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN.

Clin Infect Dis. 2008 Jun 1;46(11):1761-8. doi: 10.1086/587992.

PMID:
18433337
11.

Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.

Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF.

J Clin Virol. 2009 Mar;44(3):200-6. doi: 10.1016/j.jcv.2008.12.008. Epub 2009 Feb 4.

PMID:
19195927
12.

Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV Epidemics.

Chen M, Ma Y, Chen H, Luo H, Dai J, Song L, Yang C, Mei J, Yang L, Dong L, Jia M, Lu L.

PLoS One. 2015 Nov 12;10(11):e0142543. doi: 10.1371/journal.pone.0142543. eCollection 2015.

13.

Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.

Tanimoto T, Nguyen HC, Ishizaki A, Chung PT, Hoang TT, Nguyen VT, Kageyama S, Oka S, Pham VT, Ichimura H.

J Med Virol. 2010 Aug;82(8):1355-63. doi: 10.1002/jmv.21787.

PMID:
20572071
14.

Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.

Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, Shabestari AN, Hassanpour G, Alavian SM, Asgari F.

Arch Virol. 2012 Oct;157(10):1959-65. Epub 2012 Jun 13.

PMID:
22695769
15.

Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China.

Zhang Z, Yao Y, Wu W, Feng R, Wu Z, Cun W, Dong S.

PLoS One. 2013 Dec 17;8(12):e82598. doi: 10.1371/journal.pone.0082598. eCollection 2013.

16.

Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Ramia S, Melhem NM, Kreidieh K.

Infection. 2012 Feb;40(1):1-10. doi: 10.1007/s15010-011-0236-z. Epub 2012 Jan 12. Review.

PMID:
22237470
17.

Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.

Zhao R, Peng J, Tang L, Huang H, Liu M, Kong W, Pang B.

J Med Virol. 2013 Oct;85(10):1712-23. doi: 10.1002/jmv.23650. Epub 2013 Jul 19.

PMID:
23868809
18.

Molecular epidemiology of hepatitis C virus in a social network of injection drug users.

Aitken CK, McCaw RF, Bowden DS, Tracy SL, Kelsall JG, Higgs PG, Kerger MJ, Nguyen H, Crofts JN.

J Infect Dis. 2004 Nov 1;190(9):1586-95. Epub 2004 Sep 23.

PMID:
15478062
19.

Prevalence of hepatitis C infection among intravenous drug users in Shanghai.

Tao YL, Tang YF, Qiu JP, Cai XF, Shen XT, Wang YX, Zhao XT.

World J Gastroenterol. 2013 Aug 28;19(32):5320-5. doi: 10.3748/wjg.v19.i32.5320.

20.

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.

Xia X, Luo J, Bai J, Yu R.

Public Health. 2008 Oct;122(10):990-1003. doi: 10.1016/j.puhe.2008.01.014. Epub 2008 May 19. Review.

PMID:
18486955

Supplemental Content

Support Center